50% off Premium Yearly

NYSE:MET
This summary was created by AI, based on 1 opinions in the last 12 months.
MetLife (MET-N) has demonstrated strong performance recently, as indicated by its recent achievement of a 52-week high. The company is viewed favorably by experts for its strategic investments in solid and conservative sectors, which add to its appeal as a defensive stock. This positive sentiment suggests that MetLife is successfully navigating the financial landscape, with a focus on stability and sustainability. Investors seem to appreciate its prudent approach to asset management and its ability to deliver reliable returns in uncertain market conditions. Overall, MetLife stands out as a robust option for investors seeking defensive plays in their portfolios.
(A Top Pick July 29/13. Up 11.67%.) This should have done a whole lot better, but has been mired by regulatory concerns. Feels the US government will be labelling this as “too big to fail”, so capital, leverage and liquidity will be constrained. He would be using this fear as a way to be buying this. Still a Buy.
Fairly cheap and cheaper than all the Canadian financials. Has lots of capital, and pays a nice dividend. Has an excess of capital because they are not sure what is going to happen in the regulatory environment. If they are put in a situation where they can keep less capital, they will definitely be increasing dividend and buying back shares. Also, trades at a much cheaper multiple than the Canadian lifecos.
Lifecos do better in rising interest rates, and the consensus seems to be that this is going to happen. The 10 year in the US is hovering around 250 right now, and should back up towards 3, if growth in the 2nd half of the year is going to be as expected. The problem is, we keep missing on the economic numbers. The insurance companies have had an awful good run, so this may not be a good time to step in.
When looking at insurers, a key question is, do you think rates are going higher or lower? Certainly higher long-term rates are good for insurance companies. Secondly, many of them are focused in the wealth management side of things. He would guess that if he had to pick a direction, rates will work a little higher, but he doesn’t expect this will give a huge tailwind. His focus in financials has been more specifically in pure asset managers. This would be his 1st choice. You get great quality under something like Sun Life (SLF-T). On this company, you probably get an industry return. It has a 2+ percent return.
(A Top Pick April 2/13. Up 40.43%.) Had felt management would continue doing a good job in de-risking the business, which they did. Also, did some acquisitions in Latin America, which somewhat improves the growth profile. Really attractive share price. Will do about $5.60 in earnings this year and well north of $6 next year. If medium and long-term interest rates do rise at some point, the stock will be exceptionally well-placed. ROE is north of 10%, even in an incredibly adverse interest rate environment.
All the US lifecos face the same issues i.e. are they too big to fail. US banks have a lot of regulatory issues to deal with and he thinks this is going to move into the insurance business as well. If you want to be in this sector, this is a better company, and they have the ability to increase dividends, and to buy back a lot of stock.
Doesn’t think the stock will go below $49 and the 200 day moving average.